Evidence map›Paper›PMID 40124764›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2025

Metabolic parameters analysis of

Yongkang Qiu, Xiaoyue Zhang, Jia Cheng, Wenpeng Huang, Zhao Chen, Lele Song, Qi Yang, Xinyao Sun, Aixiang Wang, Tianyao Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yongkang QiuDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Xiaoyue ZhangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Jia ChengDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Zhao ChenDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Lele SongDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Qi YangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Xinyao SunDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Aixiang WangDepartment of Urology Pathology, Peking University First Hospital Beijing 100034, China.
Tianyao WangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Lei KangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aims to explore the diagnostic performance of

methodsA retrospective analysis was conducted on 11 patients with CDC and 27 patients with ccRCC who underwent

resultsThe median age of the 11 CDC patients was 59 years. All CDC patients were in advanced stages (18% stage III and 82% stage IV). Compare with ccRCC patients, CDC patients had higher lymph node metastases rates (72.7% vs. 22.2%,

conclusionThe utilization of

Indexed as

18F-FDGCollecting duct carcinomaPET/CTtumor-to-kidney standardized uptake value ratio (TKR)tumor-to-liver standardized uptake value ratio (TLR)

Identifiers

PMID40124764
PMCPMC11929012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.